WTI, S&P 500 and EURUSD: a difficult relationship

After weeks of firm bull sentiment, major equity markets (especially European ones) have experienced a fast correction that, although small compared to the incredible year-to-date performance, has started to disturb the overall view of investors. Such a movement has coincided with a rebound on the EUR/USD, which postponed the breakout Read more…

Want a robust quality drug pipeline? – Pay super premium!: Alexion to acquire Synageva in an $8.4bn deal

Alexion Pharmaceuticals Inc.; market cap (as of 09/05/2015): $32.54bn Synageva Biopharma Corp.; market cap (as of 09/05/2015): $7.91bn   Introduction On May 6, 2015, Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), the manufacturer of the world’s single most expensive prescription drug Soliris, and Synageva BioPharma Corp. (NASDAQ:GEVA) have entered into a definitive agreement Read more…

Is time up for Universal Banks? Deutsche Bank – Postbank case

Introduction As the financial system stabilises after the recent crisis, three distinct business models are emerging. First, focused retail institutions with a specific offering of products and services, such as American regional banks and Europe’s savings banks. Second, investment banks which also operate asset management businesses and private equity investments. Read more…

Capitan Findus docks at an American berth: Nomad Holdings buys Iglo Foods from Private Equity Permira

Nomad Holdings Ltd.; market cap (as of 01/05/2015): $576.72m Introduction On April 20, 2015 Nomad Holdings Limited (LSE: NHL), a special purpose acquisition vehicle, announced an agreement to acquire for €2.6bn, Iglo Foods Holdings Limited (Iglo Foods), from a company backed by the private equity group Permira. The acquisition would Read more…